Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Marine anticancer drugs and their relevant targets: a treasure from the ocean.

Nigam M, Suleria HAR, Farzaei MH, Mishra AP.

Daru. 2019 Jun 5. doi: 10.1007/s40199-019-00273-4. [Epub ahead of print]

2.

Pharmacological effects of gallic acid in health and diseases: A mechanistic review.

Kahkeshani N, Farzaei F, Fotouhi M, Alavi SS, Bahramsoltani R, Naseri R, Momtaz S, Abbasabadi Z, Rahimi R, Farzaei MH, Bishayee A.

Iran J Basic Med Sci. 2019 Mar;22(3):225-237. doi: 10.22038/ijbms.2019.32806.7897. Review.

3.

Implications of grape extract and its nanoformulated bioactive agent resveratrol against skin disorders.

Soleymani S, Iranpanah A, Najafi F, Belwal T, Ramola S, Abbasabadi Z, Momtaz S, Farzaei MH.

Arch Dermatol Res. 2019 May 21. doi: 10.1007/s00403-019-01930-z. [Epub ahead of print] Review.

PMID:
31115657
4.

Natural flavonoids for the prevention of colon cancer: A comprehensive review of preclinical and clinical studies.

Afshari K, Haddadi NS, Haj-Mirzaian A, Farzaei MH, Rohani MM, Akramian F, Naseri R, Sureda A, Ghanaatian N, Abdolghaffari AH.

J Cell Physiol. 2019 May 13. doi: 10.1002/jcp.28777. [Epub ahead of print] Review.

PMID:
31087338
5.

Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis.

Asgary S, Karimi R, Momtaz S, Naseri R, Farzaei MH.

Rev Endocr Metab Disord. 2019 Jun;20(2):173-186. doi: 10.1007/s11154-019-09494-z. Review.

PMID:
31065943
6.

Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Yeganeh Salehpour M, Mollica A, Momtaz S, Sanadgol N, Farzaei MH.

Clin Drug Investig. 2019 May 3. doi: 10.1007/s40261-019-00793-6. [Epub ahead of print] Review.

PMID:
31054087
7.

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Neurology Collaborators.

Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.

8.

Medicinal plants and their isolated phytochemicals for the management of chemotherapy-induced neuropathy: therapeutic targets and clinical perspective.

Oveissi V, Ram M, Bahramsoltani R, Ebrahimi F, Rahimi R, Naseri R, Belwal T, Devkota HP, Abbasabadi Z, Farzaei MH.

Daru. 2019 Mar 9. doi: 10.1007/s40199-019-00255-6. [Epub ahead of print]

9.

Plant-derived medicines for neuropathies: a comprehensive review of clinical evidence.

Ebrahimi F, Farzaei MH, Bahramsoltani R, Heydari M, Naderinia K, Rahimi R.

Rev Neurosci. 2019 Feb 15. pii: /j/revneuro.ahead-of-print/revneuro-2018-0097/revneuro-2018-0097.xml. doi: 10.1515/revneuro-2018-0097. [Epub ahead of print]

PMID:
30768427
10.

Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence.

Hajialyani M, Hosein Farzaei M, Echeverría J, Nabavi SM, Uriarte E, Sobarzo-Sánchez E.

Molecules. 2019 Feb 12;24(3). pii: E648. doi: 10.3390/molecules24030648. Review.

11.

Efficacy of topical application of standardized extract of Tragopogon graminifolius in the healing process of experimental burn wounds.

Heidari M, Bahramsoltani R, Abdolghaffari AH, Rahimi R, Esfandyari M, Baeeri M, Hassanzadeh G, Abdollahi M, Farzaei MH.

J Tradit Complement Med. 2018 Apr 27;9(1):54-59. doi: 10.1016/j.jtcme.2018.02.002. eCollection 2019 Jan.

12.

Anthocyanins in the Management of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review.

Naseri R, Farzaei F, Haratipour P, Nabavi SF, Habtemariam S, Farzaei MH, Khodarahmi R, Tewari D, Momtaz S.

Front Pharmacol. 2018 Dec 4;9:1310. doi: 10.3389/fphar.2018.01310. eCollection 2018. Review.

13.

Medicinal plants for gingivitis: a review of clinical trials.

Safiaghdam H, Oveissi V, Bahramsoltani R, Farzaei MH, Rahimi R.

Iran J Basic Med Sci. 2018 Oct;21(10):978-991. doi: 10.22038/IJBMS.2018.31997.7690. Review.

14.

Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators.

Lancet Neurol. 2019 Jan;18(1):56-87. doi: 10.1016/S1474-4422(18)30415-0. Epub 2018 Nov 26.

16.

Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Population and Fertility Collaborators.

Lancet. 2018 Nov 10;392(10159):1995-2051. doi: 10.1016/S0140-6736(18)32278-5. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

18.
19.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Mortality Collaborators.

Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

20.

Correction to: A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets.

Taghipour YD, Bahramsoltani R, Marques AM, Naseri R, Rahimi R, Haratipour P, Iranpanah A, Farzaei MH, Abdollahi M.

Daru. 2018 Dec;26(2):241-242. doi: 10.1007/s40199-018-0230-4.

Supplemental Content

Loading ...
Support Center